Literature DB >> 12743986

A high cytosol value of urokinase-type plasminogen activator (uPA) may be predictive of early relapse in primary breast cancer.

Claudio Dazzi1, Anna Cariello, Patrizia Maioli, Serena Magi, Giovanni Rosti, Petros Giovanis, Gloria Giovannini, Giuseppe Lanzanova, Maurizio Marangolo.   

Abstract

BACKGROUND: There is now much data that suggest a relationship between angiogenesis and breast cancer prognosis. Angiogenesis is a multistep process resulting from an ordered set of events and regulated by positive and negative modulators of microvessels growth and by the expression of various proteolytic enzymes.
MATERIALS AND METHODS: We prospectively evaluated VEGF and microvessels density on tumor specimen and cytosolic levels of uPA and PAI-1.
RESULTS: We enrolled 81 primary breast cancer patients. The median follow-up was 38 months. Using the median value as cutoff for the statistical analysis, we found significant correlation between cytosolic levels of uPA and PAI-1 (r = 0.61; p < .0001), between VEGF and steroid hormone receptor status (p = .01), between PAI-1 and tumor grading (p = .009), and between uPA and tumor size greater than 1 cm (p = .04). With respect to the prognosis, we observed a significant correlation between low uPA levels and RFS and an unforeseen, direct correlation between high VEGF values and better RFS.
CONCLUSIONS: Our preliminary results indicate that the cytosolic level of uPA at diagnosis may be predictive of early relapse in primary breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743986     DOI: 10.1081/cnv-120016417

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.

Authors:  Sai Murali Krishna Pulukuri; Bharathi Gorantla; Jasti S Rao
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

Review 2.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

Review 3.  Biomolecular features of clinical relevance in breast cancer.

Authors:  Maria Grazia Daidone; Angelo Paradiso; Massimo Gion; Nadia Harbeck; Fred Sweep; Manfred Schmitt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-17       Impact factor: 9.236

4.  Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth factor expression and metastasis of gallbladder cancer.

Authors:  Shu-Qiang Yue; Yan-Ling Yang; Jing-Shi Zhou; Kai-Zong Li; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

5.  Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer.

Authors:  Zheng Li; Fabrice Sergent; Michel Bolla; Yunfeng Zhou; Isabelle Gabelle-Flandin
Journal:  Oncol Lett       Date:  2014-10-17       Impact factor: 2.967

6.  Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK).

Authors:  Nancy Dos Santos; Golareh Habibi; Michelle Wang; Jennifer H Law; Heather N Andrews; Daniel Wei; Timothy Triche; Shoukat Dedhar; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.